User contributions
Jump to navigation
Jump to search
- 13:31, 25 July 2020 diff hist 0 Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- 13:30, 25 July 2020 diff hist -53 m Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 formatting edits
- 13:26, 25 July 2020 diff hist -17 Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- 13:17, 25 July 2020 diff hist -408 Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE)
- 15:48, 24 July 2020 diff hist +35 Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE)
- 15:28, 24 July 2020 diff hist +1 m Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE)
- 15:01, 24 July 2020 diff hist -15 Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- 15:01, 24 July 2020 diff hist +455 Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- 14:59, 24 July 2020 diff hist +64 COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study current
- 14:52, 24 July 2020 diff hist +150 Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
- 14:47, 24 July 2020 diff hist +829 N Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 Created page with "{| class="infobox" width=200px |style="width:100%; font-size:24px;"|'''Publication''' |- |Title || <ul>[https://www.nejm.org/doi/full/10.1056/NEJMoa2019014 Hydroxychloroquine..."
- 14:46, 24 July 2020 diff hist +1 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- 21:39, 23 July 2020 diff hist -19 Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE) →Introduction
- 21:32, 23 July 2020 diff hist +708 Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE) Added translated quote by Douste-Blazy
- 21:21, 23 July 2020 diff hist -1 m Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE) →Introduction: spelling change
- 17:40, 23 July 2020 diff hist +34 m Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE) Minor edit to COI for scientists
- 17:12, 23 July 2020 diff hist +33 m Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE) Addition of reference
- 16:04, 23 July 2020 diff hist 0 m Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE) Protected "Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE)" ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))
- 15:55, 23 July 2020 diff hist -35 Template:Main page
- 15:50, 23 July 2020 diff hist +28,889 N Gilead: Twenty-one billion reasons to discredit hydroxychloroquine (ORIGINAL ARTICLE) Article on Gilead's sphere of influence over medicine and COVID-19 therapeutics
- 20:08, 22 July 2020 diff hist +700 Template:Main page
- 20:01, 22 July 2020 diff hist +165 Template:Main page
- 17:09, 22 July 2020 diff hist +26 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro current
- 17:09, 22 July 2020 diff hist +26 Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial current
- 17:08, 22 July 2020 diff hist +26 Treating COVID-19 with Chloroquine current
- 17:08, 22 July 2020 diff hist -8 Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial current
- 17:07, 22 July 2020 diff hist +26 No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial current
- 17:06, 22 July 2020 diff hist -62 Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial
- 17:05, 22 July 2020 diff hist +26 Early hydroxychloroquine is associated with an increase of survival in COVID-19 patients: an observational study. current
- 17:04, 22 July 2020 diff hist +26 Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection current
- 17:04, 22 July 2020 diff hist +26 Risk Factors for Mortality in Patients with COVID-19 in New York City current
- 17:02, 22 July 2020 diff hist +13 Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 →Minor Issues current
- 16:59, 22 July 2020 diff hist +2 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis →Minor Issues
- 05:52, 22 July 2020 diff hist -13 Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
- 05:51, 22 July 2020 diff hist +1,171 N Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://www.nature.com/articles/s41421-020-01..."
- 05:48, 22 July 2020 diff hist +1,209 N Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://www.medrxiv.org/content/10.1101/2020...."
- 05:45, 22 July 2020 diff hist +1,496 N Treating COVID-19 with Chloroquine Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://academic.oup.com/jmcb/article/12/4/32..."
- 05:42, 22 July 2020 diff hist +2,345 N Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://jamanetwork.com/journals/jamanetworko..." current
- 05:38, 22 July 2020 diff hist +1,509 N No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://www.medrxiv.org/content/10.1101/2020...."
- 05:32, 22 July 2020 diff hist -4 Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine →Major Issues current
- 05:30, 22 July 2020 diff hist +1,380 N Early hydroxychloroquine is associated with an increase of survival in COVID-19 patients: an observational study. Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://www.preprints.org/manuscript/202005.0..."
- 05:25, 22 July 2020 diff hist +1,415 N Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://onlinelibrary.wiley.com/doi/10.1002/j..."
- 05:22, 22 July 2020 diff hist +1,587 N Risk Factors for Mortality in Patients with COVID-19 in New York City Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://link.springer.com/article/10.1007/s11..."
- 05:18, 22 July 2020 diff hist -50 COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study current
- 05:17, 22 July 2020 diff hist -117 Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea current
- 05:16, 22 July 2020 diff hist -55 Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier) current
- 03:14, 22 July 2020 diff hist -56 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- 03:13, 22 July 2020 diff hist +1,359 N Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC..." current
- 03:09, 22 July 2020 diff hist -297 Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France current
- 03:08, 22 July 2020 diff hist -1,683 Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine
- 03:07, 22 July 2020 diff hist -20 Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine
- 03:05, 22 July 2020 diff hist +3,520 N Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://pgibertie.files.wordpress.com/2020/04..."
- 03:01, 22 July 2020 diff hist -1,482 Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection current
- 03:00, 22 July 2020 diff hist +3,482 N Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://www.ahajournals.org/doi/10.1161/CIRCE..."
- 02:56, 22 July 2020 diff hist -1,517 An Effective Treatment for Coronavirus (COVID-19)
- 02:56, 22 July 2020 diff hist -1 An Effective Treatment for Coronavirus (COVID-19)
- 02:56, 22 July 2020 diff hist +920 An Effective Treatment for Coronavirus (COVID-19)
- 02:55, 22 July 2020 diff hist -72 An Effective Treatment for Coronavirus (COVID-19)
- 02:54, 22 July 2020 diff hist +3,473 N An Effective Treatment for Coronavirus (COVID-19) Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://github.com/covidtrial/info/raw/master..."
- 02:49, 22 July 2020 diff hist -9 Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
- 02:45, 22 July 2020 diff hist -262 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial current
- 02:43, 22 July 2020 diff hist +8 No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 current
- 02:42, 22 July 2020 diff hist +104 No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
- 02:38, 22 July 2020 diff hist -232 No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
- 02:36, 22 July 2020 diff hist +1 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:36, 22 July 2020 diff hist -64 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:36, 22 July 2020 diff hist -48 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:35, 22 July 2020 diff hist -4 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:35, 22 July 2020 diff hist -14 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:34, 22 July 2020 diff hist -1 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:34, 22 July 2020 diff hist -4 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:34, 22 July 2020 diff hist +91 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:32, 22 July 2020 diff hist -5 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:29, 22 July 2020 diff hist -64 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:29, 22 July 2020 diff hist -86 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 20:47, 21 July 2020 diff hist +59 About OmniJournal
- 18:24, 21 July 2020 diff hist -213 About OmniJournal
- 18:20, 21 July 2020 diff hist +564 About OmniJournal
- 05:36, 15 July 2020 diff hist -153 m Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
- 05:01, 15 July 2020 diff hist +1 m COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study grammar
- 05:01, 15 July 2020 diff hist +1 m Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis grammar
- 05:00, 15 July 2020 diff hist +42 COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study
- 04:51, 15 July 2020 diff hist +42 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- 19:48, 14 July 2020 diff hist +70 Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial
- 19:27, 14 July 2020 diff hist +1,498 N Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial RCT of HCQ in China
- 18:15, 14 July 2020 diff hist +394 Template:Main page
- 18:13, 14 July 2020 diff hist +2,164 N COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study Zelenko study
- 18:07, 14 July 2020 diff hist +2,759 N Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis Raoult 3rd study
- 18:01, 14 July 2020 diff hist -5 COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study
- 17:57, 14 July 2020 diff hist +1,694 N COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study HCQ as potential ppx
- 16:51, 14 July 2020 diff hist +2,331 N Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea HCQ S Korea study for mild disease
- 15:39, 14 July 2020 diff hist +2,324 N Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier) Created page with "{| class="infobox" width=200px |style="width:100%; font-size:24px;"|'''Publication''' |- |Title || <ul>[https://www.mediterranee-infection.com/wp-content/uploads/2020/07/Respo..."
- 15:16, 14 July 2020 diff hist +3,619 N Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 Henry Ford study on HCQ
- 15:05, 14 July 2020 diff hist +2,758 N A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 Minnesota postexposure prophylaxis study of HCQ
- 14:34, 14 July 2020 diff hist +438 No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 publication details
- 03:27, 14 July 2020 diff hist -64 Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France formatting
- 03:26, 14 July 2020 diff hist +2,125 N Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France Raoult second study on HCQ and AZ
- 03:13, 14 July 2020 diff hist +2,489 N Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Raoult first study on HCQ and AZ
- 19:10, 13 July 2020 diff hist -2 Template:Main page
- 14:26, 13 July 2020 diff hist +18,851 N Privacy policy Privacy Policy
- 14:26, 13 July 2020 diff hist +2,121 N Disclaimers Disclaimers current
- 14:24, 13 July 2020 diff hist +21,327 N Terms of Use Terms of Use
- 14:21, 13 July 2020 diff hist +10 Privacy Policy
- 13:51, 13 July 2020 diff hist +18,841 N Privacy Policy Privacy Policy
- 18:20, 6 July 2020 diff hist -1 Template:Main page
- 16:56, 6 July 2020 diff hist -120 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 16:33, 26 June 2020 diff hist +5,344 N No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 New article by James Todaro on Oxford's RECOVERY trial
- 07:07, 26 June 2020 diff hist +5 m Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis Section edit